Eleison Pharmaceuticals Overview

  • Founded
  • 2009

Founded
  • Status
  • IPO Registration

  • Employees
  • 2

Employees
  • Latest Deal Type
  • IPO

  • (Announced)
  • Financing Rounds
  • 4

Eleison Pharmaceuticals General Information

Description

Developer of specialty pharmaceuticals and life-saving drugs for cancer treatment. The company acquires, develops and commercializes clinical-stage drug therapies for lung, pancreatic, brain and other types of cancers, thus providing patients with a new hope to fight these rare and life-threatening diseases.

Contact Information

Ownership Status
In IPO Registration
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 100 Overlook Center
  • 2nd Floor
  • Princeton, NJ 08540
  • United States
+1 (215) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Eleison Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Eleison Pharmaceuticals‘s full profile, request access.

Request a free trial

Eleison Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of specialty pharmaceuticals and life-saving drugs for cancer treatment. The company acquires, develops and co
Drug Discovery
Princeton, NJ
2 As of 2022
0000
00000000 0000

000000

ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate vel
0000 000000000
Bethesda, MD
00 As of 0000
00000
000000000 - 00000

000000

bore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation
0000000000000
Burlington, MA
00 As of 0000
00000
0000000000 0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Eleison Pharmaceuticals Competitors (21)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Northwest Biotherapeutics Corporation Bethesda, MD 00 00000 000000000 - 00000
000000000 000000 Venture Capital-Backed Burlington, MA 00 00000 0000000000 0 00000
000000 00000000000 Formerly VC-backed Needham, MA 00 00000 00000000 00000
0000 00000000 Formerly VC-backed Stamford, CT 00 00000 000000&0 00000
0000000 000000 Venture Capital-Backed Barcelona, Spain 00 000.00 0000000000 0 000.00
You’re viewing 5 of 21 competitors. Get the full list »

Eleison Pharmaceuticals Patents

Eleison Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020262112-A1 Combination therapeutic regimens with 1,6-dibromo-1,6-dideoxy-dulcitol Pending 24-Apr-2019 0000000000
CA-3137952-A1 Combination therapeutic regimens with 1,6-dibromo-1,6-dideoxy-dulcitol Pending 24-Apr-2019 0000000000
EP-3958848-A1 Combination therapeutic regimens with 1,6-dibromo-1,6-dideoxy-dulcitol Pending 24-Apr-2019 0000000000
JP-2022529990-A Combination treatment regimen with 1,6-dibromo-1,6-dideoxy-zlucitol Pending 24-Apr-2019 0000000000
US-20220142941-A1 Combination therapeutic regimens with 1,6-dibromo-1,6-dideoxy-dulcitol Pending 24-Apr-2019 A61K31/047
To view Eleison Pharmaceuticals’s complete patent history, request access »

Eleison Pharmaceuticals Executive Team (8)

Name Title Board Seat Contact Info
Edwin Thomas Chief Executive Officer, President and Board Member
Guangtao Zhang Ph.D Senior Vice President, CMC and Business Development in Asia & President, China
Richard Christie Ph.D Vice President, Business Development
Patrick Maguire Ph.D Chief Medical Officer
William Fricker Chief Financial Officer
You’re viewing 5 of 8 executive team members. Get the full list »

Eleison Pharmaceuticals Board Members (6)

Name Representing Role Since
00000 0000 Self Board Member 000 0000
00000 0000000 Capital Solutions Board Member 000 0000
0000 0000000000 00 Self Board Member 000 0000
0000 0000000 Self Board Member 000 0000
0000000 0000 00.0 Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Eleison Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Eleison Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Eleison Pharmaceuticals‘s full profile, request access.

Request a free trial